BACKGROUND AND PURPOSE: Aneurysm embolization using Guglielmi detachable coils (GDC)
is gaining increasing acceptance as a viable alternative to surgery in the treatment of …

Background: Ischemic stroke has no approved treatments to enhance recovery. ALD-401 is
an enriched population of aldehyde dehydrogenase-bright stem cells, capable of reducing …

MR imaging with intravenous gadolinium has greatly enhanced our ability to detect and
delineate intracranial metastases as well as to differentiate them from other disease processes. …

Lipomatous uterine tumors are rare benign neoplasms that can be difficult to differentiate
from benign cystic ovarian teratomas. However, if a fat containing mass can be clearly …

Stroke affects more than 700,000 people each year in the United States and is the third
leading cause of death behind heart disease and cancer. It is the leading cause of health care …

Background The effect of endovascular thrombectomy that is performed more than 6 hours
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …

Background and Purpose— The only Food and Drug Administration (FDA)-approved treatment
for acute ischemic stroke is tissue plasminogen activator (tPA) given intravenously within …

OBJECTIVE: Advances in surgical and endovascular techniques have improved treatment
for paraclinoid aneurysms. A combined surgical and endovascular team can formulate …

Object. Although the pathophysiology of spinal dural arteriovenous fistulas (AVFs) has recently
been elucidated, the optimal treatment strategy for these lesions has yet to be defined. …

Background and Purpose— Acute stroke from occlusion of the intracranial internal carotid
artery (ICA) generally has a poor prognosis and appears to respond poorly to intravenous …